What are the guidelines for prescribing ELAVIL (Amitriptyline) to patients, particularly those with a history of cardiovascular disease, glaucoma, or urinary retention, for conditions such as depression, anxiety, or chronic pain?

ELAVIL (Amitriptyline) Prescribing Guidelines

Avoid Amitriptyline in Patients with Cardiovascular Disease, Glaucoma, or Urinary Retention

Amitriptyline should not be prescribed to patients with cardiovascular disease, angle-closure glaucoma, or urinary retention due to significant risks of arrhythmias, acute glaucoma attacks, and urinary obstruction. 1 The American Heart Association explicitly recommends against tricyclic antidepressants like amitriptyline, stating they have "significant cardiovascular side effects, including hypertension, hypotension, and arrhythmias, and should be avoided" in patients with cardiovascular disease. 2

---

Cardiovascular Contraindications

Amitriptyline causes myocardial depression, arrhythmias, and conduction abnormalities that become clinically significant under stress or in patients with existing heart disease. 1, 3

• Specific cardiovascular risks include:

  • Arrhythmias and sinus tachycardia, particularly at high doses 1
  • Prolongation of cardiac conduction time 1
  • Myocardial infarction and stroke have been reported with tricyclic antidepressants 1
  • Depressant effect on myocardial contractility that manifests under stress, with ejection fraction dropping significantly (from 70.6% to 66.4%) even in patients without pre-existing heart disease 3

• Close supervision is required when amitriptyline is given to patients with any cardiovascular disorder 1

• The 2024 American Heart Association guidelines for palliative cardiovascular care explicitly state that monoamine oxidase inhibitors and tricyclic antidepressants should be avoided due to these cardiovascular side effects 2

---

Glaucoma Contraindications

Amitriptyline should be used with extreme caution in patients with a history of angle-closure glaucoma or increased intraocular pressure; even average doses may precipitate an acute glaucoma attack. 1

• The FDA label specifically warns that "in patients with angle-closure glaucoma, even average doses may precipitate an attack" 1
• This is due to amitriptyline's potent atropine-like (anticholinergic) action 1

---

Urinary Retention Contraindications

Amitriptyline should be used with caution in patients with a history of urinary retention due to its anticholinergic effects. 1

• The FDA label lists urinary retention as a specific precaution requiring careful consideration before prescribing 1
• Anticholinergic activity can exacerbate urinary obstruction 1

---

Preferred Alternatives for Depression and Anxiety

For Patients with Cardiovascular Disease:

Sertraline is the first-line antidepressant for patients with cardiovascular disease. 2, 4

• Sertraline has been studied extensively in coronary heart disease and heart failure and appears safe 2
• It has a lower risk of QTc prolongation compared to citalopram or escitalopram 2, 4
• No renal dose adjustment required 4

Mirtazapine is a safe alternative with additional benefits:

• Demonstrated cardiovascular safety profile 2, 4
• Provides appetite stimulation, which may benefit malnourished patients 2, 4
• Can be used for sleep disturbances 2

For Insomnia in Cardiovascular Patients:

Cognitive behavioral therapy for insomnia is first-line treatment before any medication. 2

• If pharmacotherapy is needed, sedating antidepressants (trazodone, mirtazapine) or melatonin receptor agonists (ramelteon) may be considered 2
• However, trazodone carries cardiovascular risks including orthostatic hypotension and cardiac arrhythmias 5
• Mirtazapine is considered safer than trazodone for cardiovascular patients 5

---

Limited Role for Chronic Pain

While amitriptyline demonstrates efficacy for neuropathic pain conditions (post-herpetic neuralgia, diabetic neuropathy), the cardiovascular and anticholinergic risks often outweigh benefits, particularly in elderly patients or those with comorbidities. 6

• Achieves good or moderate response in up to two-thirds of patients with post-herpetic neuralgia and three-quarters with painful diabetic neuropathy 6
• Analgesic effect shows dose-response (75 mg superior to 25-50 mg) unrelated to mood elevation 7
• However, adverse effects (dry mouth, sedation, orthostatic hypotension, tachycardia) are common even at low doses and increase significantly at higher doses 6, 7
• Orthostatic hypotension and tachycardia pose particular problems in elderly patients 6

For chronic pain in patients with cardiovascular disease, consider alternative agents:

• Low-dose oral opioids (immediate-release formulations for intermittent use) are generally well tolerated and safe 2
• Avoid NSAIDs due to cardiovascular toxicity, renal toxicity, and increased heart failure hospitalization risk 2
• Avoid gabapentin and pregabalin in patients with cardiovascular disease due to fluid retention, weight gain, and heart failure exacerbation risk 2, 4

---

Critical Prescribing Precautions

If amitriptyline must be prescribed despite contraindications:

• Start with the lowest possible dose and titrate carefully to minimize adverse effects 6
• Write prescriptions for the smallest quantity feasible due to suicide risk in depressed patients 1
• Monitor closely for clinical worsening, suicidality, and unusual behavioral changes, especially during initial months of therapy or dose changes 1
• Screen patients for bipolar disorder before initiating treatment, as amitriptyline may precipitate manic episodes 1
• Discontinue several days before elective surgery when possible 1
• Use with extreme caution in elderly patients, those with impaired liver function, hyperthyroid patients, or those receiving thyroid medication 1
• Avoid concurrent use with alcohol, barbiturates, or other CNS depressants due to potentiation effects 1

---

Common Pitfalls to Avoid

• Do not prescribe amitriptyline as first-line therapy for depression or anxiety in patients with any cardiovascular history 2
• Do not assume "low doses are safe" in cardiovascular patients—myocardial depression occurs even at therapeutic concentrations and manifests under stress 3
• Do not overlook glaucoma history—even average doses can precipitate acute attacks 1
• Do not combine with other anticholinergic medications in patients with urinary retention or glaucoma risk 1
• Do not prescribe large quantities due to overdose lethality and suicide risk 1